Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
03/25/2010 | WO2010032764A1 Therapeutic/prophylactic agent for prostate cancer |
03/25/2010 | WO2010032020A2 Modified bacterial cell |
03/25/2010 | WO2010031744A1 Whey and thymus function |
03/25/2010 | WO2010031190A1 Culture medium for myoblasts, precursors thereof and derivatives thereof |
03/25/2010 | WO2010012088A8 Soluble igf receptors as anti-angiogenic agents |
03/25/2010 | WO2010010364A3 Process for the purification of oils |
03/25/2010 | WO2010008491A3 Lactose compositions with decreased lactose content |
03/25/2010 | WO2010007502A3 Platelet fraction deriving from placental blood |
03/25/2010 | WO2009148488A3 Use of oncolytic herpes viruses for killing cancer stem cells |
03/25/2010 | WO2009138583A3 Use of a composition containing ergosterol or a natural extract of a vegetable or animal microorganism |
03/25/2010 | WO2009120966A3 Reinforced tissue graft |
03/25/2010 | US20100076465 Fibrin-based nerve repair conduit and method of producing the same |
03/25/2010 | US20100074964 Super brown cream |
03/25/2010 | US20100074962 Degradation of prion protein and reduced prion infectivity by earthworm homogenates |
03/25/2010 | US20100074945 Mutated ras peptides for generation of cd8+ cytotoxic t lymphocytes |
03/25/2010 | US20100074939 Harmine compounds for promoting bone growth |
03/25/2010 | US20100074933 Cell And Enzyme Compositions For Modulating Bile Acids, Cholesterol and Triglycerides |
03/25/2010 | US20100074908 Human synthetic single-chain antibodies directed against the common epitope of mutant P53 and their uses |
03/25/2010 | US20100074902 Methods for human allografting |
03/25/2010 | US20100074888 Animal having modification in mgat2 gene |
03/25/2010 | US20100074887 Methods for Treating and Diagnosing Fibrotic and Fibroproliferative Diseases |
03/25/2010 | US20100074878 Probiotic bacterium: lactobacillus fermentum |
03/25/2010 | US20100074876 Calcium phosphate delivery vehicles for osteoinductive proteins |
03/25/2010 | US20100074875 Composition containing human umbilical cord blood-derived mesenchymal stem cell for inducing differentiation and proliferation of neural precursor cells or neural stem cells to neural cells |
03/25/2010 | US20100074874 Synthetic multi-layer structures comprising biopolymer fibres |
03/25/2010 | US20100074873 Live bacteria product |
03/25/2010 | US20100074872 Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota |
03/25/2010 | US20100074871 Probiotic infant products |
03/25/2010 | US20100074869 Multifunctional Cytokines |
03/25/2010 | DE102008047068A1 Verfahren und Vorrichtung zur Trennung von Blut unter Einsatz einer Zentrifuge Method and apparatus for separation of blood using a centrifuge |
03/25/2010 | CA2739368A1 Markers of induced pluripotent stem cells |
03/25/2010 | CA2737805A1 Probiotic infant products |
03/25/2010 | CA2737771A1 Whey and thymus function |
03/25/2010 | CA2737655A1 Probiotic infant products |
03/25/2010 | CA2737619A1 Nutritional support of the immune system during anti-cancer treatment |
03/25/2010 | CA2736885A1 Method for using a bacillus subtilis strain to enhance animal health |
03/25/2010 | CA2736774A1 Nutritional support to prevent and/or mitigate bone marrow toxicity from a cancerous tumor |
03/25/2010 | CA2736747A1 Nutritional support to prevent or moderate bone marrow paralysis or neutropenia during anti-cancer treatment |
03/24/2010 | EP2165715A1 Therapeutic agent for cancer, and method for treatment of cancer |
03/24/2010 | EP2165713A1 Whey and thymus function |
03/24/2010 | EP2164541A2 Fluid concentrator, autologous concentrated body fluids, and uses thereof |
03/24/2010 | EP2164505A1 Treatment of chronic lung disease |
03/24/2010 | EP2164504A1 A method of administration of a pulmonary surfactant |
03/24/2010 | EP2081566B1 Improved biological effects of compositions comprising rosmarinic acid |
03/24/2010 | EP1180938B1 Agents, compositions and methods utilizing the same useful in treating or preventing alzheimer disease |
03/24/2010 | CN101679953A Mutant reoviruses and methods of making and using |
03/24/2010 | CN101679951A Telencephalic glial-restricted cell populations and related compositions and methods |
03/24/2010 | CN101679938A Probiotic bifidobacterium strains |
03/24/2010 | CN101679935A Novel bacteria isolated from fresh honey or the honey producing tract of honey bees |
03/24/2010 | CN101679517A Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90 |
03/24/2010 | CN101678071A Prophylactic agent for renal failure |
03/24/2010 | CN101678055A Supplemention of maternal diet |
03/24/2010 | CN101678054A Probiotics in a pre- and/or post surgical environment |
03/24/2010 | CN101678053A Method for treating or preventing systemic inflammation |
03/24/2010 | CN101678052A Probiotic, gram-positive bacteria for the prophylaxis, suppression, or elimination of allergic reactions in humans |
03/24/2010 | CN101678051A Agent for accelerating the increase in and/or preventing the decrease in blood adiponectin level, and visceral fat accumulation inhibitor |
03/24/2010 | CN101678050A Human umbilical tissue-derived cell compositions for the treatment of incontinence |
03/24/2010 | CN101678049A Tissue fragment compositions for the treatment of incontinence |
03/24/2010 | CN101678048A Use of isoosmotic seawater-based ionic solutions for manufacturing medical devices for the prevention of complications of the common cold or of the flu syndrome |
03/24/2010 | CN101677848A Use of noncalcium zeolites with added calcium salt in hemostatic devices and products |
03/24/2010 | CN101677606A Equol-containing extract, method for production thereof, method for extraction of equol, and equol-containing food |
03/24/2010 | CN101677583A Lactobacillus helveticus bacterium composition for treatment of atopic dermatitis |
03/24/2010 | CN101676268A frangible compounds for pathogen inactivation |
03/24/2010 | CN101675992A Beta-amyloid-analogue-t-cell epitop vaccine |
03/24/2010 | CN101675989A Qi-supplementing, spleen-invigorating, kidney-tonifying and blood-generating traditional Chinese medicine composition |
03/24/2010 | CN101675988A A middle-Jiao-warming, cold-dispelling, stasis-dissolving and toxin-dispelling traditional Chinese medicine composition |
03/24/2010 | CN101675986A Lupus III traditional Chinese medicine composition |
03/24/2010 | CN101675983A Warming and tonifying agent for qi-deficiency syndrome |
03/24/2010 | CN101675981A Paste agent for treating low back pain |
03/24/2010 | CN101675980A Traditional Chinese medicine composition for treating cancer |
03/24/2010 | CN101675979A Qi-supplementing, blood circulation- invigorating, lung-heat-clearing and phlegm- resolving traditional Chinese medicine composition |
03/24/2010 | CN101675977A Formula comprising black alum for treating hepatopathy |
03/24/2010 | CN101675975A Ultra-high biomass two-way super-molecule diversity multi-source traditional Chinese medicine preparation |
03/24/2010 | CN101675972A Blood-enriching tranquillizing traditional Chinese medicine composition |
03/24/2010 | CN101675968A Pharmaceutical composition for treating lumbocrural pain and its preparation method |
03/24/2010 | CN101675966A Medicament for treating psoriasis |
03/24/2010 | CN101675965A Formula comprising pinellia ternate for treating epigastric pain |
03/24/2010 | CN101675960A Lupus II traditional Chinese medicine composition |
03/24/2010 | CN101675959A Limaigubang capsule |
03/24/2010 | CN101675955A A fresh pomegranate rind formula for treating chronic gastritis |
03/24/2010 | CN101675953A Traditional Chinese medicine composition for treating psoriasis and its preparation method |
03/24/2010 | CN101675952A Patch for prevention and control of bronchial asthma |
03/24/2010 | CN101675948A Traditional Chinese medicine composition for treating apoplexy |
03/24/2010 | CN101675939A Traditional Chinese medicine for treating eye keratitis and preparation method |
03/24/2010 | CN101675938A Preparation method and use of a novel peptide type immunizing agent whole-egg protein peptide |
03/24/2010 | CN101675937A A method for preparing the forming of a composite bilirubinate |
03/24/2010 | CN100594927C Medicine for treating chronic enteritis, chronic bacterial diarrhea and intestine cancer |
03/24/2010 | CN100594923C Oral administered medicinal composition and its preparation and usage |
03/24/2010 | CN100594920C Kidney-replenishing sperm-supplementing granule |
03/24/2010 | CN100594917C Externally applied medicine for curing psoriasis and producing method thereof |
03/24/2010 | CN100594916C Plaster for reducing the blood pressure |
03/24/2010 | CN100594804C Compound rhodamine oil soft capsule and method for preparing the same |
03/24/2010 | CN100594797C Protein capable of antioxidant activity separated from acaleph and application thereof |
03/23/2010 | US7682623 Pharmaceutical composition for topical application |
03/23/2010 | CA2639023A1 Bioscience iii |
03/23/2010 | CA2607237C The use of free radical scavengers for protecting and treating skin and hair damages caused by chemotherapy |
03/23/2010 | CA2378426C Bifidobacteria capable of preventing diarrhea |
03/23/2010 | CA2329000C Stabilised virus preparation |
03/23/2010 | CA2223412C Method for prolonging the expression of a gene of interest using soluble ctla4 molecules |
03/23/2010 | CA2201106C Anti-inflammatory factor, method of isolation, and use |